Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bladder Cancer

  Free Subscription


11.10.2021

1 Am J Surg Pathol
1 Bladder Cancer
1 BMC Cardiovasc Disord
1 Cancer Immunol Res
1 Cell Death Discov
1 Cell Rep Med
1 Clin Epidemiol
2 Clin Genitourin Cancer
1 Clin Med Insights Oncol
1 Clin Nucl Med
1 Eur Urol
1 Exp Cell Res
1 Front Cell Dev Biol
1 Front Mol Biosci
3 Front Oncol
1 Front Pharmacol
1 Gulf J Oncolog
1 Hinyokika Kiyo
1 Immunogenetics
1 J Clin Invest
1 J Coll Physicians Surg Pak
1 J Int Med Res
1 J Med Primatol
1 J Pathol
1 Kaohsiung J Med Sci
1 Micron
1 Mol Biol Rep
1 Nature
1 Occup Environ Med
1 Oncogene
1 Pathologe
3 Pathology
1 Scand J Urol
1 Support Care Cancer
1 Urol Oncol
1 Urologe A
1 Urology
1 Virchows Arch
1 Virusdisease
1 World J Clin Cases
2 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg Pathol

  1. WANG G, Yuan R, Zhou C, Guo C, et al
    Urinary Large Cell Neuroendocrine Carcinoma: A Clinicopathologic Analysis of 22 Cases.
    Am J Surg Pathol. 2021;45:1399-1408.
    PubMed         Abstract available


    Bladder Cancer

  2. REYES RM, Rios E, Barney S, Hugen CM, et al
    A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2021;7:285-295.
    PubMed         Abstract available


    BMC Cardiovasc Disord

  3. LIANG HZ, Zhao H, Gao J, Cao CF, et al
    Epirubicin-induced Kounis syndrome.
    BMC Cardiovasc Disord. 2021;21:133.
    PubMed         Abstract available


    Cancer Immunol Res

  4. JI N, Mukherjee N, Shu ZJ, Reyes RM, et al
    gammadelta T cells support antigen-specific alphabeta T cell-mediated antitumor responses during BCG treatment for bladder cancer.
    Cancer Immunol Res. 2021 Oct 4. pii: 2326-6066.CIR-21-0285.
    PubMed         Abstract available


    Cell Death Discov

  5. ZHANG Y, Chen X, Lin J, Jin X, et al
    Biological functions and clinical significance of long noncoding RNAs in bladder cancer.
    Cell Death Discov. 2021;7:278.
    PubMed         Abstract available


    Cell Rep Med

  6. MI H, Bivalacqua TJ, Kates M, Seiler R, et al
    Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture.
    Cell Rep Med. 2021;2:100382.
    PubMed         Abstract available


    Clin Epidemiol

  7. RASTMANESH R
    Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: A Short Comment [Letter].
    Clin Epidemiol. 2021;13:893-894.
    PubMed        


    Clin Genitourin Cancer

  8. CULINE S, Harter V, Gravis G, Flechon A, et al
    Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
    Clin Genitourin Cancer. 2021 Sep 8. pii: S1558-7673(21)00162.
    PubMed         Abstract available

  9. HORLEMANN B, Wurnschimmel C, Hoeh B, Sorce G, et al
    Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients.
    Clin Genitourin Cancer. 2021 Sep 1. pii: S1558-7673(21)00160.
    PubMed         Abstract available


    Clin Med Insights Oncol

  10. RHEA LP, Aragon-Ching JB
    Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer.
    Clin Med Insights Oncol. 2021;15:11795549211044963.
    PubMed         Abstract available


    Clin Nucl Med

  11. EROL O, Ergul N, Algun Gedik A, Beyhan E, et al
    Synchronous Bilateral Adrenal Gland Metastases of Bladder Carcinoma Revealed on 18F-FDG PET/CT.
    Clin Nucl Med. 2021 Apr 21. pii: 00003072-900000000-96075.
    PubMed         Abstract available


    Eur Urol

  12. ALFRED WITJES J
    Re: Five-factor Prognostic Model for Survival of Post-platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors.
    Eur Urol. 2021;80:113.
    PubMed        


    Exp Cell Res

  13. YANG D, Ma Y, Zhao P, Ma J, et al
    HMMR is a downstream target of FOXM1 in enhancing proliferation and partial epithelial-to-mesenchymal transition of bladder cancer cells.
    Exp Cell Res. 2021 Oct 5:112860. doi: 10.1016/j.yexcr.2021.112860.
    PubMed         Abstract available


    Front Cell Dev Biol

  14. TAO H, Liao Y, Yan Y, He Z, et al
    BRCC3 Promotes Tumorigenesis of Bladder Cancer by Activating the NF-kappaB Signaling Pathway Through Targeting TRAF2.
    Front Cell Dev Biol. 2021;9:720349.
    PubMed         Abstract available


    Front Mol Biosci

  15. WANG H, Luo W, Wang X, Xue D, et al
    Testicular Nuclear Receptor 4 Regulates Proliferation and Apoptosis of Bladder Cancer via Bcl-2.
    Front Mol Biosci. 2021;8:670409.
    PubMed         Abstract available


    Front Oncol

  16. WANG K, Gu Y, Ni J, Zhang H, et al
    Combination of Total Psoas Index and Albumin-Globulin Score for the Prognosis Prediction of Bladder Cancer Patients After Radical Cystectomy: A Population-Based Study.
    Front Oncol. 2021;11:724536.
    PubMed         Abstract available

  17. LAO Y, Li X, He L, Guan X, et al
    Association Between Alcohol Consumption and Risk of Bladder Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies.
    Front Oncol. 2021;11:696676.
    PubMed         Abstract available

  18. ZHU H, Jia X, Wang Y, Song Z, et al
    M6A Classification Combined With Tumor Microenvironment Immune Characteristics Analysis of Bladder Cancer.
    Front Oncol. 2021;11:714267.
    PubMed         Abstract available


    Front Pharmacol

  19. CHENG C, Qiu D, Chen J, Zu X, et al
    Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis.
    Front Pharmacol. 2021;12:707271.
    PubMed         Abstract available


    Gulf J Oncolog

  20. MOHAMMED AA, Elshentenawy A, Elsayed FM
    The effect of body mass index on clinico-pathological features and survival outcome in metastatic bladder carcinoma.
    Gulf J Oncolog. 2021;1:14-20.
    PubMed         Abstract available


    Hinyokika Kiyo

  21. KIMURA S, Terada N, Otsuka I, Kimura T, et al
    [A Cohort Study on the Prognosis of Patients with Urothelial Carcinoma Using the Miyazaki Urological Cancer Database (MUCD)].
    Hinyokika Kiyo. 2021;67:407-412.
    PubMed         Abstract available


    Immunogenetics

  22. EL-GEDAMY M, El-Khayat Z, Abol-Enein H, El-Said A, et al
    Rs-10889677 variant in interleukin-23 receptor may contribute to creating an inflammatory milieu more susceptible to bladder tumourigenesis: report and meta-analysis.
    Immunogenetics. 2021;73:207-226.
    PubMed         Abstract available


    J Clin Invest

  23. SINGH AK, Netea MG, Bishai WR
    BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases.
    J Clin Invest. 2021;131.
    PubMed         Abstract available


    J Coll Physicians Surg Pak

  24. CUI Y, Zhou T
    Diagnostic Value of Urinary MicroRNAs for Bladder Cancer in Asia.
    J Coll Physicians Surg Pak. 2021;31:1207-1213.
    PubMed         Abstract available


    J Int Med Res

  25. LUO J, Xu J, Ou L, Zhou Y, et al
    Role of hypermethylated-lncRNAs in the prognosis of bladder cancer patients.
    J Int Med Res. 2021;49:3000605211049946.
    PubMed         Abstract available


    J Med Primatol

  26. JOHNSON AL, Dozier BL, Colgin LMA
    Urothelial carcinoma in the urinary bladder of a Japanese macaque (Macaca fuscata).
    J Med Primatol. 2021;50:141-143.
    PubMed         Abstract available


    J Pathol

  27. SIRAB N, Drubay D, Maille P, Popova T, et al
    Multilayer spectrum of intratumoral heterogeneity in basal bladder cancer.
    J Pathol. 2021 Oct 6. doi: 10.1002/path.5813.
    PubMed         Abstract available


    Kaohsiung J Med Sci

  28. ZHANG CM, Song LD, Wang JW, Ye HB, et al
    Role of miR-490-3p in blocking bladder cancer growth through targeting the RNA-binding protein PCBP2.
    Kaohsiung J Med Sci. 2021 Oct 7. doi: 10.1002/kjm2.12457.
    PubMed         Abstract available


    Micron

  29. ADAMI BS, Diz FM, Oliveira Goncalves GP, Reghelin CK, et al
    Morphological and mechanical changes induced by quercetin in human T24 bladder cancer cells.
    Micron. 2021;151:103152.
    PubMed         Abstract available


    Mol Biol Rep

  30. KOKSAL KARAYILDIRIM C, Nalbantsoy A, Karabay Yavasoglu NU
    Prunetin inhibits nitric oxide activity and induces apoptosis in urinary bladder cancer cells via CASP3 and TNF-alpha genes.
    Mol Biol Rep. 2021 Oct 2. pii: 10.1007/s11033-021-06719.
    PubMed         Abstract available


    Nature

  31. POWLES T, Assaf ZJ, Davarpanah N, Banchereau R, et al
    ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.
    Nature. 2021;595:432-437.
    PubMed         Abstract available


    Occup Environ Med

  32. KOUTROS S
    The need for, and challenges associated with, assessing occupational work histories for bladder and other occupational cancers.
    Occup Environ Med. 2021;78:623-624.
    PubMed        


    Oncogene

  33. REN S, Zhang N, Shen L, Lu Y, et al
    Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA/RhoC mRNA and impairing bladder cancer invasion.
    Oncogene. 2021 Oct 6. pii: 10.1038/s41388-021-02033.
    PubMed         Abstract available


    Pathologe

  34. MEIJER RP
    Urothelial cancer organoids: a tool for bladder cancer research.
    Pathologe. 2021 Oct 8. pii: 10.1007/s00292-021-00988.
    PubMed         Abstract available


    Pathology

  35. TAKAHARA T, Murase Y, Tsuzuki T
    Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes.
    Pathology. 2021;53:56-66.
    PubMed         Abstract available

  36. MCKENNEY JK
    Urothelial carcinoma in situ: diagnostic update.
    Pathology. 2021;53:86-95.
    PubMed         Abstract available

  37. SAMARATUNGA H, Delahunt B, Yaxley J, Egevad L, et al
    Tumour-like lesions of the urinary bladder.
    Pathology. 2021;53:44-55.
    PubMed         Abstract available


    Scand J Urol

  38. BOBJER J, Hagberg O, Aljabery F, Gardmark T, et al
    Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study.
    Scand J Urol. 2021 Oct 8:1-5. doi: 10.1080/21681805.2021.1987980.
    PubMed         Abstract available


    Support Care Cancer

  39. DOS REIS PF, de Franca PS, Dos Santos MP, Martucci RB, et al
    Influence of nutritional status and frailty phenotype on health-related quality of life of patients with bladder or kidney cancer.
    Support Care Cancer. 2021;29:5139-5150.
    PubMed         Abstract available


    Urol Oncol

  40. XU Z, Zeng H, Liu Z, Jin K, et al
    Poor clinical outcomes and immunoevasive contexture in SIRPalpha(+) tumor-associated macrophages enriched muscle-invasive bladder cancer patients.
    Urol Oncol. 2021 Sep 30. pii: S1078-1439(21)00408.
    PubMed         Abstract available


    Urologe A

  41. DRAGER DL
    [Perioperative nutritional interventions in patients undergoing radical cystectomy for bladder cancer].
    Urologe A. 2021 Oct 4. pii: 10.1007/s00120-021-01670.
    PubMed        


    Urology

  42. SUI W, Hall ME, Barocas DA, Chang SS, et al
    Association between surgical volume and survival among patients with variant histologies of bladder cancer.
    Urology. 2021 Oct 1. pii: S0090-4295(21)00884.
    PubMed         Abstract available


    Virchows Arch

  43. HAGHAYEGHI K, Lu S, Matoso A, Schiff SF, et al
    Association of current molecular subtypes in urothelial carcinoma with patterns of muscularis propria invasion.
    Virchows Arch. 2021;479:515-521.
    PubMed         Abstract available


    Virusdisease

  44. SINGH MK, Jain M, Shyam H, Shankar P, et al
    Associated pathogenesis of bladder cancer and SARS-CoV-2 infection: a treatment strategy.
    Virusdisease. 2021 Sep 24:1-3. doi: 10.1007/s13337-021-00742.
    PubMed         Abstract available


    World J Clin Cases

  45. ZHANG YS, Li XJ, Zhang YH, Hu TC, et al
    Carbon ion radiotherapy for bladder cancer: A case report.
    World J Clin Cases. 2021;9:7833-7839.
    PubMed         Abstract available


    World J Urol

  46. TZELVES L, Mourmouris P, Skolarikos A
    Does bipolar energy provide any advantage over monopolar surgery in transurethral resection of non-muscle invasive bladder tumors? A systematic review and meta-analysis.
    World J Urol. 2021;39:1093-1105.
    PubMed         Abstract available

  47. BENSON CR, Ajay D, Barrett-Harlow BL, Cunningham KG, et al
    Ureteroenteric anastomosis in orthotopic neobladder creation: do urinary tract infections impact stricture rate?
    World J Urol. 2020 May 28. pii: 10.1007/s00345-020-03266.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: